Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioStock: BioInvent offers guidance on upcoming milestones

When pharmaceutical company BioInvent recently invited investors, analysts and media to Stockholm, CEO Martin Welschof painted a picture of busy times ahead. BioStock had the privilege to chat with Welschof, who offered guidance on what to expect from the company in the upcoming months.Read the full interview with Martin Welschof at biostock.se: https://www.biostock.se/en/2021/11/bioinvent-offers-guidance-on-upcoming-milestones/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Issue and repurchase of class C shares for incentive program

The board of directors for Medicover AB (publ) has today resolved to issue 1,200,000 new class C shares and to immediately thereafter repurchase such 1,200,000 issued class C shares, for the purpose of the long term performance-based share programs for key individuals as approved by the annual general meetings held on 3 May 2019, 30 April 2020 and 29 April 2021 (the “Plan 2019”, the “Plan 2020” and the “Plan 2021”). Today’s resolution by the board of directors was passed based on the authorisation granted by the annual general meeting held on 29 April 2021. Nordea Bank Abp will

Lactoferrin supplements could aid recovery of COVID19

The findings of a study, headed by Dr Hamid Merchant from the Department of Pharmacy at the University of Huddersfield, is one of the first meta-analyses carried out using multiple independent lactoferrin research studies.  The study has made evident that the administration of lactoferrin, of which has proven to be a key ingredient for our natural defence systems against invading viruses, shows promising efficacy in reducing the risk of RTIs and also has the potential to be used adjunct to COVID19.THE antiviral properties of lactoferrin makes it a great natural supplement that could also be

Epiroc completes acquisition of specialist in mining vehicle battery conversions

Stockholm, Sweden: Epiroc, a leading productivity and sustainability partner for the mining and infrastructure industries, has completed the acquisition of the business and assets of FVT Research Inc., a Canadian company with expertise in converting diesel-powered mining machines to battery-electric vehicles.FVT Research, based in Vancouver, Canada, designs diesel-to-battery conversion kits and rebuilds mining machines to electric versions. The company has also recently been part of a successful project to convert the diesel-powered Epiroc Scooptram ST1030 loader to battery electric. FVT

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 2nd November 2021, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 26,166,036 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

Invitation to Kesko Corporation’s Digital Hour virtual investor event

Invitation to Kesko Corporation’s Digital Hour virtual investor event on 1 December 2021 at 1 pm (EET). Kesko is a forerunner in trading sector digitalization. Kesko’s digital sales today total €1.4 billion. We now invite analysts, investors and media to attend our digital-themed investor event on Wednesday, 1 December 2021, from 1 pm to 2 pm Finnish time. The event will focus on digitalisation and Kesko’s digital strategy, and will be held in English. Event speakers: Mikko Helander, President and CEO Anni Ronkainen, EVP, Chief Digital Officer Jukka Erlund, EVP, Chief

MEDIVIR AB – INTERIM REPORT JANUARY – SEPTEMBER 2021

Positive MIV-818 data presented at ESMO. New positive data and renegotiated agreement for remetinostatJuly – SeptemberFinancial summary for the quarter · Net turnover amounted to SEK 0.8 (1.1) million. · The loss before interest, tax, depreciation and amortization (EBITDA) amounted to SEK -11.7 (5.2) million. Basic and diluted earnings per share amounted to SEK -0.26 (0.19) and SEK -0.26 (0.19) respectively. · Cash flow from operating activities amounted to SEK -20.0 (-17.1) million. · Liquid assets and short-term investments at the end of the period amounted to SEK 225.9 (

Etrion Releases Third Quarter 2021 Results

November 3, 2021, Geneva, Switzerland – Etrion Corporation (“Etrion” or the “Company”, and, together with its subsidiaries, the “Group”) (OMX: ETX) released today its condensed consolidated interim financial statements and related management’s discussion and analysis (“MD&A”) for the three and nine months ended September 30, 2021. Q3-21 HIGHLIGHTS Corporate · On July 28, 2021, the Company completed the sale of its TK interests in the 9.5 MW Misawa energy project to the Consortium, for gross proceeds of JPY 1.5 billion (approximately $13.5 million). · On August 24, 2021, the

Volvo and Holcim jointly work in a project to use autonomous electric haulers

Volvo Autonomous Solutions and Holcim Switzerland have partnered to jointly test and further develop the use of autonomous electric haulers in a limestone quarry. The two companies are dedicated to seeking infrastructure and transport solutions that are safe, efficient, innovative and sustainable.Volvo Autonomous Solutions  and Holcim Switzerland  have entered a collaboration to jointly test and further develop the use of autonomous electric haulers in a limestone quarry. Holcim’s quarry Gabenchopf in Siggenthal has

Metso Outotec to invest in increased manufacturing capacity in Alwar India

Metso Outotec Corporation’s press release on November 3, 2021, at 9:00 a.m. EETMetso Outotec will invest in extending its current manufacturing capacity of mobile track-mounted crushing and screening equipment in Alwar India. The total Alwar production value is planned to grow by 30% from the current level and global track mounted mobile machine capacity by 15%. Construction of the new factory facilities is planned to start in early 2022, and be completed by the end of the year. The increased capacity in India will be used for the manufacturing of McCloskey mobile and Lokotrack equipment,

Metsä Tissue, Germany welcomes new junior professionals after successful apprenticeships

Metsä Tissue, a part of Metsä Group, welcomes 20 junior professionals on board after their successful apprenticeship periods. These new employees will now start their professional careers at Metsä Tissue as trained paper technologists, industrial mechanics, electronics technicians for industrial engineering, machine and plant operators and industrial clerks.Metsä Tissue has a decades-long history of training young talents at its two tissue mills in Germany. By providing training within the company, Metsä Tissue Germany is able to better ensure its long-term skilled labour needs in a

Holmströmgruppen employs Christian Fredefors

Holmströmgruppen, the asset manager of Holmström Fastigheter Holding AB (publ), has employed Christian Fredefors as CFO.Christian Fredefors has previously worked at Brunswick Real Estate Capital Advisory as an Investment Manager. Before that he worked with financing and transactions at Hemfosa and Swedbank. “It feels great to join Holmströmgruppen, which is an expanding and successful company within the residential property market and private equity investments.” says Christian Fredefors “We look forward to further developing our business with Christian.” Says, Erik Rune CEO,

Eltel Group: Interim report January–September 2021

July–September 2021 · Net sales EUR 193.8 million (226.7). Total growth -14.5% and organic growth1) in segments -13.8% · Operative EBITA2) EUR 4.1 million (6.7) and operative EBITA margin 2.1% (2.9) · Operative EBITA2) in segments EUR 7.7 million (8.6) and operative EBITA margin in segments 4.4% (4.3) · Items affecting comparability EUR 0.0 million (-0.7) · Operating result (EBIT) EUR 4.0 million (5.8) and EBIT margin 2.1% (2.6) · Net result EUR 1.8 million (3.1) · Earnings per share EUR 0.01 (0.02), basic and diluted · Cash flow from operating activities EUR -7.8

Essity holds digital Capital Markets Day today

The hygiene and health company Essity is holding a digital Capital Markets Day today. Essity will present the company’s strategy and continued transformation journey, as well as its work to achieve the Group’s goal of profitable growth, net zero emissions by 2050 and improved well-being for people across the globe.The Capital Markets Day will be livestreamed from Essity’s headquarters in Stockholm. Link to the Capital Markets Day live stream: https://essity.videosync.fi/2021-11-03-cmd If you wish to ask questions during the day, please call one of the following numbers: +44 333 300

CONCENTRIC INTERIM REPORT JANUARY – SEPTEMBER 2021

THIRD QUARTER · Net sales: MSEK 515 (324) – reported sales were up +59% year-on-year. After adjusting for the impact of currency (–4%) and Allied Enterprises (+6%), sales in constant currency year-on-year were up +57%. · Operating income: MSEK 114 (57), generating an operating margin of 22.2% (17.5). · Net income for the period: MSEK 91 (40); basic EPS of SEK 2.39 (1.06). · Cash flow from operating activities: MSEK 69 (51). · Acquisition: On 29 October 2021 the acquisition of Engineered Machine Products, Inc was completed for a purchase price of MSEK 1,260 on a cash free,

Orexo Q3 2021 Interim Report

Steady progression on our journey to build a broader and stronger Orexo Q3 2021 highlights · Total net revenues of SEK 145.9 m (150.3) · Net earnings of -52.0 SEK  m (-84.9) · EBITDA of SEK -47.4 m (-20.9) · US Pharma segment (ZUBSOLV® US) net revenues of SEK 136.4 m (143.8), in local currency USD 15.8 m (16.2), US Pharma EBIT of SEK 78.5 m (72.4) · Cash flow from operating activities of SEK -79.7 m (-12.9), cash balance of SEK 588.1 m (593.3) · Earnings per share before dilution amounted to -1.51 (-2.45) · Commercial partnership agreement signed with Sober Grid,

OX2 acquires rights to 150 MW wind power project in Sweden from Vattenfall

Wednesday 3 November 2021, 08.00 CET – Non-regulatory press release  OX2 has agreed to acquire from Vattenfall the rights to build the Klevberget wind farm in the municipality of Ånge, Västernorrland County, Sweden.Under the agreement, OX2 will acquire 100 percent of the project from Vattenfall. The wind farm holds a legally binding permit and has an estimated capacity of approximately 150 MW. It will be an addition to OX2’s Swedish project development portfolio for late-stage onshore wind power.  A group of local landowners developed the project until 2018, when necessary permit was

Calliditas announces poster presentations at ASN Digital Kidney Week 2021

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced upcoming presentations concerning Nefecon, its lead product candidate, at the American Society of Nephrology (ASN) annual Kidney Week 2021 conference, which will be held virtually November 2–7, 2021.Both posters will be presented at the ‘Glomerular Diseases: Immunology and Inflammation in IgANP, C3GP, TMA, and Nephrotic Diseases’ session, which will take place on November 4 between 10:00am and 12:00pm (PDT). Dr Karen Molyneux from the Mayer IgA Nephropathy Laboratory at the University of

Q3 2021 Trading Update

International Personal Finance plc Q3 2021 trading update 3 November 2021 International Personal Finance plc specialises in providing unsecured consumer credit to 1.7 million customers across 11 markets.  We operate the world's largest home credit business and a fintech operator, IPF Digital. Highlights o Strong operational performance and well -positioned for further growth o  Rebuild strategy proving highly effective and delivering sustained growth momentum o  Improving consumer demand and selective relaxation of credit

Loomis interim report January – September 2021

Quarter 3, 2021Revenue for the third quarter amounted to SEK 5,135 million (4,709). Real growth was 11 percent(-7) and organic growth was 6 percent (-9).   Operating income (EBITA)1) amounted to SEK 581 million (517) and the operating margin was 11.3 percent (11.0). Excluding Loomis Pay the operating margin was 12.0 percent (11.5).   Income before taxes amounted to SEK 437 million (361) and income after taxes was SEK 297 million (246).   Earnings per share before dilution amounted to SEK 3.96 (3.27) and after dilution 3.95 SEK (3.27).   Cash flow from operating

Vestas – Interim Financial Report, Third Quarter 2021

Vestas Wind Systems A/S, Aarhus, 3 November 2021Company announcement no. 18/2021 Summary: Revenue increased compared to third quarter 2020, while EBIT decreased as a consequence of supply chain challenges. Combined order backlog of more than EUR 47bn. Full-year guidance updated. In the third quarter of 2021, Vestas generated revenue of EUR 5,538m – an increase of 16 percent compared to the year-earlier period. EBIT before special items decreased by EUR 87m to EUR 325m. This resulted in an EBIT margin before special items of 5.9 percent, compared to 8.6 percent in the third quarter

Marika Fredriksson to step down as Vestas’ CFO and be replaced by Hans Martin Smith, currently CFO of Vestas Northern & Central Europe

Vestas Wind Systems A/S, Aarhus, 03 November 2021Company announcement no. 17/2021 After almost nine years as Chief Financial Officer (CFO) of Vestas, Marika Fredriksson has decided to hand over the financial reigns to Hans Martin Smith, currently CFO Vestas Northern & Central Europe (NCE), by 1 March 2022. Having joined in May 2013, Marika has played an integral role in making Vestas the global leader in wind energy. Most prominently, Marika led Vestas’ Finance function during the company’s turnaround, which was followed by significant growth from a EUR 6bn company to well beyond EUR

Dignitana Announces Decision by Medicare to Reassign Payment for Scalp Cooling

New classification enables reimbursement to cancer centers providing DigniCap to chemotherapy patientsDignitana , world leader in scalp cooling innovation, announces that the U.S. Centers for Medicare & Medicaid Services (CMS) has reassigned payment for scalp cooling for Medicare claims filed using CPT code 0662T. This treatment has been reassigned to New Technology APC 1520 with a National Average Payment of $1,850.50, effective January 1, 2022. "This decision ensures that thousands of cancer patients will now have access to life-changing scalp cooling therapy

Transactions in connection with share buy-back programme

On 4 March 2021, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the “Safe Harbour Regulation”). On 18 March 2021, the share buy-back programme was increased by DKK 15 million, thereby increasing the maximum aggregate purchase price of the shares to be bought back under the programme to DKK 115 million. The share buy-back

There are no items matching the current filter
There are no more items matching the current filter
Back to top